CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 42 filers reported holding CATALYST BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -96.0% | 500 | -89.7% | 0.00% | – |
| Q1 2021 | $25,000 | -43.2% | 4,864 | -30.2% | 0.00% | – |
| Q4 2020 | $44,000 | +780.0% | 6,964 | +557.6% | 0.00% | – |
| Q3 2020 | $5,000 | -61.5% | 1,059 | -53.8% | 0.00% | – |
| Q2 2020 | $13,000 | +85.7% | 2,294 | +71.2% | 0.00% | – |
| Q3 2019 | $7,000 | -83.7% | 1,340 | -76.8% | 0.00% | – |
| Q2 2019 | $43,000 | +79.2% | 5,776 | +96.4% | 0.00% | – |
| Q1 2019 | $24,000 | -14.3% | 2,941 | -14.9% | 0.00% | – |
| Q4 2018 | $28,000 | -20.0% | 3,456 | +5.9% | 0.00% | – |
| Q3 2018 | $35,000 | +25.0% | 3,262 | +37.0% | 0.00% | – |
| Q2 2018 | $28,000 | – | 2,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |